Transfection of PDCD5 sensitizes colorectal cancer cells to cisplatin-induced apoptosis in vitro and in vivo.
暂无分享,去创建一个
[1] Yingyu Chen,et al. Recombinant human PDCD5 sensitizes chondrosarcomas to cisplatin chemotherapy in vitro and in vivo , 2010, Apoptosis.
[2] Linda Mol,et al. Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer. , 2009, The New England journal of medicine.
[3] E. Van Cutsem,et al. Cetuximab and chemotherapy as initial treatment for metastatic colorectal cancer. , 2009, The New England journal of medicine.
[4] A. Jemal,et al. Cancer Statistics, 2009 , 2009, CA: a cancer journal for clinicians.
[5] H. Lenz,et al. Chemotherapy with targeted agents for the treatment of metastatic colorectal cancer. , 2009, The oncologist.
[6] R. Beart,et al. Rates and predictors of chemotherapy use for stage III colon cancer , 2008, Cancer.
[7] G. Jean,et al. Epidermal Growth Factor Receptor Monoclonal Antibodies for the Treatment of Metastatic Colorectal Cancer , 2008, Pharmacotherapy.
[8] B. Wolpin,et al. Systemic treatment of colorectal cancer. , 2008, Gastroenterology.
[9] A. Seifalian,et al. Principles and applications of gene therapy in colon cancer. , 2008, Journal of gastrointestinal and liver diseases : JGLD.
[10] K. Omura. Advances in Chemotherapy against Advanced or Metastatic Colorectal Cancer , 2008, Digestion.
[11] J. Rhee,et al. Celecoxib attenuates 5-fluorouracil-induced apoptosis in HCT-15 and HT-29 human colon cancer cells. , 2007, World journal of gastroenterology.
[12] Yan-rong Liu,et al. Abnormal expression of the programmed cell death 5 gene in acute and chronic myeloid leukemia. , 2006, Leukemia research.
[13] Wei Guo,et al. Eliminating Established Tumor in nu/nu Nude Mice by a Tumor Necrosis Factor-α-Related Apoptosis-Inducing Ligand–Armed Oncolytic Adenovirus , 2006, Clinical Cancer Research.
[14] S. Howell,et al. DNA mismatch repair and p53 function are major determinants of the rate of development of cisplatin resistance , 2006, Molecular Cancer Therapeutics.
[15] Ugo Pastorino,et al. Association of the PDCD5 locus with lung cancer risk and prognosis in smokers. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] B. Kang,et al. Expression of programmed cell death 5 gene involves in regulation of apoptosis in gastric tumor cells , 2006, Apoptosis.
[17] Y. Wang,et al. Short interfering RNA against the PDCD5 attenuates cell apoptosis and caspase-3 activity induced by Bax overexpression , 2006, Apoptosis.
[18] Stephen W. Fesik,et al. Promoting apoptosis as a strategy for cancer drug discovery , 2005, Nature Reviews Cancer.
[19] Dong Wang,et al. Cellular processing of platinum anticancer drugs , 2005, Nature Reviews Drug Discovery.
[20] W. Han,et al. An alternative form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by PDCD5 overexpression , 2004, Journal of Cell Science.
[21] D. Fraker,et al. Combined 5-Fluorouracil/Systemic Interferon-β Gene Therapy Results in Long-Term Survival in Mice with Established Colorectal Liver Metastases , 2004, Clinical Cancer Research.
[22] Z. Siddik,et al. Cisplatin: mode of cytotoxic action and molecular basis of resistance , 2003, Oncogene.
[23] Dalong Ma,et al. Transfer of anti-TFAR19 monoclonal antibody into HeLa cells by in situ electroporation can inhibit the apoptosis. , 2002, Life sciences.
[24] E. Jeffes,et al. Living T9 glioma cells expressing membrane macrophage colony-stimulating factor produce immediate tumor destruction by polymorphonuclear leukocytes and macrophages via a "paraptosis"-induced pathway that promotes systemic immunity against intracranial T9 gliomas. , 2002, Blood.
[25] H. Kawasaki,et al. Reduction of hepatocarcinogenesis by ursodeoxycholic acid in rats. , 2002, Carcinogenesis.
[26] G. Fu,et al. Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[27] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[28] L. Young,et al. High-level, beta-catenin/TCF-dependent transgene expression in secondary colorectal cancer tissue. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.
[29] N. Abraham,et al. Synergetic Effects of Retrovirus IFN-alpha Gene Transfer and 5-FU on Apoptosis of Colon Cancer Cells , 1999, Acta Haematologica.
[30] H. Liu,et al. TFAR19, a novel apoptosis-related gene cloned from human leukemia cell line TF-1, could enhance apoptosis of some tumor cells induced by growth factor withdrawal. , 1999, Biochemical and biophysical research communications.
[31] C. Borner,et al. Bcl-2 prolongs cell survival after Bax-induced release of cytochrome c , 1998, Nature.
[32] L. Milas,et al. Kinetics of cisplatin‐induced apoptosis in murine mammary and ovarian adenocarcinomas , 1995, International journal of cancer.
[33] M. Gurney,et al. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. , 1994, The American journal of pathology.
[34] C. Sorenson,et al. Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. , 1990, Journal of the National Cancer Institute.
[35] L. Tanoue. Cancer Statistics, 2009 , 2010 .
[36] F. Gao,et al. Reduced expression of PDCD5 is associated with high-grade astrocytic gliomas. , 2008, Oncology reports.
[37] Seth M. Cohen,et al. Cisplatin: from DNA damage to cancer chemotherapy. , 2001, Progress in nucleic acid research and molecular biology.
[38] J. Sudbø,et al. Gene-expression profiles in hereditary breast cancer. , 2001, The New England journal of medicine.
[39] N. Dubrawsky. Cancer statistics , 1989, CA: a cancer journal for clinicians.